Ademetionine treatment cost analysis of patients with intrahepatic cholestasis and non-alcoholic fatty disease-Reference-Cited by-同舟云学术

Ademetionine treatment cost analysis of patients with intrahepatic cholestasis and non-alcoholic fatty disease

Published:2022-04-30 Issue:1 Volume: Page:41-52
ISSN:2618-8473
Container-title:Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice
language:
Short-container-title:GCP

Author:

Zhuravleva M. V.¹^ORCID,Kukushkin G. V.²,Luchinina E. V.³^ORCID,Shelekhova T. V.³^ORCID,Kameneva T. R.⁴^ORCID,Kuznetsova E. V.⁵^ORCID,Luchinin E. A.⁵^ORCID

Affiliation:

1. Federal State Autonomous Educational Institution of Higher Education I. M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation (Sechenovskiy University); Federal State Budgetary Institution “Scientifi c Centre for Expert Evaluation of Medicinal Products” of the Ministry of Health of the Russian Federation

2. Federal State Autonomous Educational Institution of Higher Education “N. I. Pirogov Russian National Research Medical University” of the Ministry of Health of the Russian Federation

3. Federal State Budgetary Educational Institution of Higher Education “V. I. Razumovsky Saratov State Medical University” of the Ministry of Healthcare of the Russian Federation

4. City Clinical Hospital named after M. P. Konchalovskiy

5. Research Institute for Healthcare Organization and Medical Management

Publisher

Publishing House OKI

Subject

General Medicine

Reference20 articles.

1. Silivontchik NN, Adamenko AI, Bogush LS. Аdemetionine: physiological eff ects and use in treatment of liver diseases. Mezhdunarodnye obzory: klinicheskaya praktika i zdorov’e. 2017;(2):33–49. (In Russ).

2. Order of the Government of the Russian Federation No. 3073-r dated 11/23/2020 “Ob utverzhdenii perechnya zhiznenno neobkhodimykh i vazhneishikh lekarstvennykh preparatov dlya meditsinskogo primeneniya na 2021 god”. (In Russ). http://publication.pravo.gov.ru/Document/View/0001202011250016.

3. Instructions for the medical use of the drug Heptral (ademetionine) 28.04.2017. (In Russ).

4. Stelmakh VV, Kovalenko AL, Kozlov VK. Efficiency of the preparation “Remaxol, solution for infusions” in the therapy of patients with the syndrome of intraupecular cholestasis in chronic diffusion diseases of the liver. Experimental and Clinical Gastroenterology. 2018;152(4):89–98. (In Russ).

5. Golovanova EV. Diagnostika i lechenie vnutripechenochnogo kholestaza pri khronicheskikh zabolevaniyakh pecheni [dissertation]. Moscow, 2008. (In Russ). https://www.dissercat.com/content/diagnostikai-lechenie-vnutripechenochnogo-kholestaza-pri-khronicheskikhzabolevaniyakh-pech.